The Genetic and Molecular Epidemiology Group, led by Núria Malats at the Spanish National Cancer Research Centre (CNIO), shows the need to continue to improve these classifications: the team published in the journal Gut the results of a European case-control study showing that one of the most recently identified types of diabetes, type 3c or pancreatogenic diabetes, could also be an early manifestation of pancreatic cancer. Read more. . .
As biomedical sciences incorporate increasingly sophisticated methodologies and technologies, our understanding of diseases improves. Diabetes is a clear example since new classifications are being added to the traditional classification into type 1 and type 2 diabetes; these new classifications are based on genetic and molecular characteristics that improve diagnosis and treatment.